ZYUS Life Sciences Appoints Dr. Julie Stakiw as Chief Medical Officer to Advance Phase 2 Oncology Pain Program and Strengthen Clinical Development Leadership In a pivotal step toward accelerating its clinical development strategy and reinforcing its commitment to addressing the…
HistoSonics Expands Access to Groundbreaking Non-Invasive Liver Tumor Treatment as Highmark Covers Histotripsy for 7 Million Members In a pivotal development for patients battling liver tumors, HistoSonics, the medical technology company behind the innovative Edison® Histotripsy System, announced that Highmark…
ViiV Healthcare Broadens Voluntary Licensing Deal with MPP to Include Long-Acting Injectable HIV Treatment in Global Access Push GSK plc (LSE/NYSE: GSK) announced that its majority-owned subsidiary, ViiV Healthcare—a global leader in HIV treatment and prevention, with Pfizer and Shionogi…
Walgreens Boots Alliance Shareholders Overwhelmingly Approve Acquisition by Sycamore Partners Walgreens Boots Alliance, announced a significant milestone on the path to its planned acquisition by Sycamore Partners Management, L.P. Shareholders of the global pharmacy-led health and retail company voted overwhelmingly…
AI Meets Ancient Wisdom: UN Agencies Launch Report on Artificial Intelligence in Traditional Medicine Artificial intelligence (AI) is opening new frontiers for traditional medicine, combining centuries-old healing practices with cutting-edge technologies to enhance safety, personalization, effectiveness, and accessibility of care.…
Jazz Pharmaceuticals Appoints Renee Gala as Chief Executive Officer, Marking a New Chapter in Company’s Growth Strategy Pharmaceuticals today announced a significant leadership transition that marks a pivotal moment in the company’s evolution. The Board of Directors has unanimously appointed…
AbbVie and IGI Therapeutics Sign Exclusive Global Licensing Agreement for Trispecific Antibody ISB 2001 AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive global licensing agreement for ISB 2001, IGI’s…
Glass Lewis Endorses Sinovac’s Current Board, Urges Shareholders to Reject Former Directors’ Takeover Attempt Sinovac Biotech Ltd., a leading Chinese biopharmaceutical company, announced today that Glass Lewis, a top independent corporate governance advisory firm, has recommended that shareholders vote in…
ISS and Glass Lewis Endorse Sinovac’s Current Board Ahead of Crucial Shareholder Vote Sinovac Biotech Ltd. a leading Chinese biopharmaceutical company, announced that Institutional Shareholder Services Inc. (ISS), one of Wall Street’s most respected independent corporate governance research and proxy…
Global Sickle Cell Disease Treatment Market Poised for Robust Growth Through 2035 The global sickle cell disease (SCD) treatment market is set to witness substantial growth from 2025 to 2035, driven by increasing disease prevalence, advancements in therapeutic development, and…
Global Cancer Vaccine Market Poised for Strong Growth Through 2031, Driven by Innovation in Precision Immunotherapy and Personalized Medicine The global cancer vaccine market has experienced robust growth over recent years and is expected to continue on this trajectory, propelled…
In-Depth Report Sheds Light on Distribution Deals in the Pharma and Biotech Sectors (2020–2025) A newly updated research publication, Distribution Deals in Pharmaceuticals and Biotechnology, offers a comprehensive analysis of distribution partnerships formed within the pharmaceutical and biotechnology industries from…
